The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Celiac Disease Testing Market Research Report 2025
Synopsis
Celiac disease is a digestive disorder that causes the body to have difficulty absorbing nutrients like fat, calcium, iron, and folate. It is an autoimmune disease in which gluten-containing foods cause damage to the small intestine lining.Celiac disease is diagnosed using a combination of serologic tests, small bowel biopsy, and a gluten-free diet response. Several serologic antibody tests can be used as initial tests. Antigliadin antibodies are no longer recommended for initial testing due to their low sensitivity and specificity.
Global Celiac Disease Testing market is projected to reach US$ 1208.8 million in 2029, increasing from US$ 760 million in 2022, with the CAGR of 6.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Celiac Disease Testing market research.
The global celiac disease testing market refers to the market for diagnostic tests used to detect celiac disease, an autoimmune disorder where the body’s immune system reacts to gluten, a protein found in wheat, barley, and rye. Celiac disease can cause damage to the small intestine and lead to various symptoms, including gastrointestinal discomfort, malabsorption of nutrients, and other complications.
The market for celiac disease testing includes both laboratory-based tests and point-of-care (POC) tests. Laboratory-based tests involve analyzing blood samples for specific antibodies that are associated with celiac disease, such as anti-tissue transglutaminase (anti-tTG) antibodies, anti-endomysial antibodies (EMA), and anti-deamidated gliadin peptide (anti-DGP) antibodies. POC tests are designed to provide rapid and convenient results at the point of patient care, such as doctor’s offices or pharmacies.
The global celiac disease testing market is driven by several factors, including the increasing awareness and diagnosis of celiac disease, the growing demand for early and accurate detection, and the rising prevalence of the disease worldwide. According to the Celiac Disease Foundation, it is estimated that about 1% of the global population is affected by celiac disease.
In terms of geography, North America dominates the celiac disease testing market, followed by Europe. This can be attributed to the high awareness levels among healthcare professionals and patients, well-established healthcare infrastructure, and the presence of key market players in these regions. However, with increasing awareness and healthcare infrastructure development in emerging economies, such as China and India, the Asia-Pacific region is expected to witness substantial growth in the celiac disease testing market.
Key players in the global celiac disease testing market include diagnostic laboratories, healthcare providers, and companies specializing in diagnostic tests. These companies focus on developing innovative and accurate diagnostic tools for celiac disease, as well as providing comprehensive testing services. Additionally, research efforts are ongoing to discover new biomarkers and improve the efficiency and specificity of celiac disease testing.
Overall, the global celiac disease testing market is expected to experience significant growth in the coming years, driven by factors such as increasing awareness, improving diagnostic technologies, and rising global prevalence of celiac disease.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Celiac Disease Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
PRIMA Lab SA
Glutenostics
NanoRepro
Thermo Fisher Scientific
Targeted Genomics
YorkTest
Biohit Oyj
Labsystems Diagnostics Oy
Biomerica
Smartblood
Segment by Type
Serologic Tests
Genetic Tests
Intestinal Biopsies
Others
Segment by Application
Hospitals
Diagnostic Laboratories
Home Care
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Celiac Disease Testing report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Celiac disease is a digestive disorder that causes the body to have difficulty absorbing nutrients like fat, calcium, iron, and folate. It is an autoimmune disease in which gluten-containing foods cause damage to the small intestine lining.Celiac disease is diagnosed using a combination of serologic tests, small bowel biopsy, and a gluten-free diet response. Several serologic antibody tests can be used as initial tests. Antigliadin antibodies are no longer recommended for initial testing due to their low sensitivity and specificity.
Global Celiac Disease Testing market is projected to reach US$ 1208.8 million in 2029, increasing from US$ 760 million in 2022, with the CAGR of 6.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Celiac Disease Testing market research.
The global celiac disease testing market refers to the market for diagnostic tests used to detect celiac disease, an autoimmune disorder where the body’s immune system reacts to gluten, a protein found in wheat, barley, and rye. Celiac disease can cause damage to the small intestine and lead to various symptoms, including gastrointestinal discomfort, malabsorption of nutrients, and other complications.
The market for celiac disease testing includes both laboratory-based tests and point-of-care (POC) tests. Laboratory-based tests involve analyzing blood samples for specific antibodies that are associated with celiac disease, such as anti-tissue transglutaminase (anti-tTG) antibodies, anti-endomysial antibodies (EMA), and anti-deamidated gliadin peptide (anti-DGP) antibodies. POC tests are designed to provide rapid and convenient results at the point of patient care, such as doctor’s offices or pharmacies.
The global celiac disease testing market is driven by several factors, including the increasing awareness and diagnosis of celiac disease, the growing demand for early and accurate detection, and the rising prevalence of the disease worldwide. According to the Celiac Disease Foundation, it is estimated that about 1% of the global population is affected by celiac disease.
In terms of geography, North America dominates the celiac disease testing market, followed by Europe. This can be attributed to the high awareness levels among healthcare professionals and patients, well-established healthcare infrastructure, and the presence of key market players in these regions. However, with increasing awareness and healthcare infrastructure development in emerging economies, such as China and India, the Asia-Pacific region is expected to witness substantial growth in the celiac disease testing market.
Key players in the global celiac disease testing market include diagnostic laboratories, healthcare providers, and companies specializing in diagnostic tests. These companies focus on developing innovative and accurate diagnostic tools for celiac disease, as well as providing comprehensive testing services. Additionally, research efforts are ongoing to discover new biomarkers and improve the efficiency and specificity of celiac disease testing.
Overall, the global celiac disease testing market is expected to experience significant growth in the coming years, driven by factors such as increasing awareness, improving diagnostic technologies, and rising global prevalence of celiac disease.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Celiac Disease Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
PRIMA Lab SA
Glutenostics
NanoRepro
Thermo Fisher Scientific
Targeted Genomics
YorkTest
Biohit Oyj
Labsystems Diagnostics Oy
Biomerica
Smartblood
Segment by Type
Serologic Tests
Genetic Tests
Intestinal Biopsies
Others
Segment by Application
Hospitals
Diagnostic Laboratories
Home Care
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Celiac Disease Testing report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Celiac Disease Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Serologic Tests
1.2.3 Genetic Tests
1.2.4 Intestinal Biopsies
1.2.5 Others
1.3 Market by Application
1.3.1 Global Celiac Disease Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Home Care
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Celiac Disease Testing Market Perspective (2018-2029)
2.2 Celiac Disease Testing Growth Trends by Region
2.2.1 Global Celiac Disease Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Celiac Disease Testing Historic Market Size by Region (2018-2023)
2.2.3 Celiac Disease Testing Forecasted Market Size by Region (2024-2029)
2.3 Celiac Disease Testing Market Dynamics
2.3.1 Celiac Disease Testing Industry Trends
2.3.2 Celiac Disease Testing Market Drivers
2.3.3 Celiac Disease Testing Market Challenges
2.3.4 Celiac Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Celiac Disease Testing Players by Revenue
3.1.1 Global Top Celiac Disease Testing Players by Revenue (2018-2023)
3.1.2 Global Celiac Disease Testing Revenue Market Share by Players (2018-2023)
3.2 Global Celiac Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Celiac Disease Testing Revenue
3.4 Global Celiac Disease Testing Market Concentration Ratio
3.4.1 Global Celiac Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Celiac Disease Testing Revenue in 2022
3.5 Celiac Disease Testing Key Players Head office and Area Served
3.6 Key Players Celiac Disease Testing Product Solution and Service
3.7 Date of Enter into Celiac Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Celiac Disease Testing Breakdown Data by Type
4.1 Global Celiac Disease Testing Historic Market Size by Type (2018-2023)
4.2 Global Celiac Disease Testing Forecasted Market Size by Type (2024-2029)
5 Celiac Disease Testing Breakdown Data by Application
5.1 Global Celiac Disease Testing Historic Market Size by Application (2018-2023)
5.2 Global Celiac Disease Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Celiac Disease Testing Market Size (2018-2029)
6.2 North America Celiac Disease Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Celiac Disease Testing Market Size by Country (2018-2023)
6.4 North America Celiac Disease Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Celiac Disease Testing Market Size (2018-2029)
7.2 Europe Celiac Disease Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Celiac Disease Testing Market Size by Country (2018-2023)
7.4 Europe Celiac Disease Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Celiac Disease Testing Market Size (2018-2029)
8.2 Asia-Pacific Celiac Disease Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Celiac Disease Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Celiac Disease Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Celiac Disease Testing Market Size (2018-2029)
9.2 Latin America Celiac Disease Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Celiac Disease Testing Market Size by Country (2018-2023)
9.4 Latin America Celiac Disease Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Celiac Disease Testing Market Size (2018-2029)
10.2 Middle East & Africa Celiac Disease Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Celiac Disease Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Celiac Disease Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PRIMA Lab SA
11.1.1 PRIMA Lab SA Company Detail
11.1.2 PRIMA Lab SA Business Overview
11.1.3 PRIMA Lab SA Celiac Disease Testing Introduction
11.1.4 PRIMA Lab SA Revenue in Celiac Disease Testing Business (2018-2023)
11.1.5 PRIMA Lab SA Recent Development
11.2 Glutenostics
11.2.1 Glutenostics Company Detail
11.2.2 Glutenostics Business Overview
11.2.3 Glutenostics Celiac Disease Testing Introduction
11.2.4 Glutenostics Revenue in Celiac Disease Testing Business (2018-2023)
11.2.5 Glutenostics Recent Development
11.3 NanoRepro
11.3.1 NanoRepro Company Detail
11.3.2 NanoRepro Business Overview
11.3.3 NanoRepro Celiac Disease Testing Introduction
11.3.4 NanoRepro Revenue in Celiac Disease Testing Business (2018-2023)
11.3.5 NanoRepro Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Celiac Disease Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Celiac Disease Testing Business (2018-2023)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Targeted Genomics
11.5.1 Targeted Genomics Company Detail
11.5.2 Targeted Genomics Business Overview
11.5.3 Targeted Genomics Celiac Disease Testing Introduction
11.5.4 Targeted Genomics Revenue in Celiac Disease Testing Business (2018-2023)
11.5.5 Targeted Genomics Recent Development
11.6 YorkTest
11.6.1 YorkTest Company Detail
11.6.2 YorkTest Business Overview
11.6.3 YorkTest Celiac Disease Testing Introduction
11.6.4 YorkTest Revenue in Celiac Disease Testing Business (2018-2023)
11.6.5 YorkTest Recent Development
11.7 Biohit Oyj
11.7.1 Biohit Oyj Company Detail
11.7.2 Biohit Oyj Business Overview
11.7.3 Biohit Oyj Celiac Disease Testing Introduction
11.7.4 Biohit Oyj Revenue in Celiac Disease Testing Business (2018-2023)
11.7.5 Biohit Oyj Recent Development
11.8 Labsystems Diagnostics Oy
11.8.1 Labsystems Diagnostics Oy Company Detail
11.8.2 Labsystems Diagnostics Oy Business Overview
11.8.3 Labsystems Diagnostics Oy Celiac Disease Testing Introduction
11.8.4 Labsystems Diagnostics Oy Revenue in Celiac Disease Testing Business (2018-2023)
11.8.5 Labsystems Diagnostics Oy Recent Development
11.9 Biomerica
11.9.1 Biomerica Company Detail
11.9.2 Biomerica Business Overview
11.9.3 Biomerica Celiac Disease Testing Introduction
11.9.4 Biomerica Revenue in Celiac Disease Testing Business (2018-2023)
11.9.5 Biomerica Recent Development
11.10 Smartblood
11.10.1 Smartblood Company Detail
11.10.2 Smartblood Business Overview
11.10.3 Smartblood Celiac Disease Testing Introduction
11.10.4 Smartblood Revenue in Celiac Disease Testing Business (2018-2023)
11.10.5 Smartblood Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
